Rachman Ilya M 4
4 · Immix Biopharma, Inc. · Filed Jun 20, 2025
Insider Transaction Report
Form 4
Rachman Ilya M
DirectorCEO and Chairman
Transactions
- Purchase
Common Stock
2025-06-18$2.29/sh+2,178$4,999→ 1,138,437 total
Footnotes (1)
- [F1]Volume-weighted average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.